Renal Cancer - Results from #2620

Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging. August 12, 2020

Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes. August 12, 2020

LncRNA MEG3 mediates renal cell cancer progression by regulating ST3Gal1 transcription and EGFR sialylation. August 11, 2020

Fumarate hydratase as a therapeutic target in renal cancer. August 11, 2020

Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma. August 11, 2020

The immunology of renal cell carcinoma. August 10, 2020

High-Dimensional Cytometry (ExCYT) and Mass Spectrometry of myeloid infiltrate in clinically localized clear cell Renal Cell Carcinoma identifies novel potential myeloid targets for immunotherapy. August 10, 2020

In vitro evidence of NLRP3 inflammasome regulation by histone demethylase LSD2 in renal cancer: a pilot study. August 10, 2020

Usefulness of multidetector computed tomography to differentiate between renal cell carcinoma and oncocytoma. a model validation. August 7, 2020

Development and Validation of a Deep-Learning Model to Assist with Renal Cell Carcinoma Histopathologic Interpretation. August 7, 2020

Bilateral ovarian metastasis of clear-cell renal cell carcinoma: A case report. August 7, 2020

[A Case of Myocardial Metastasis of Renal Cell Cancer Treated with Nivolumab]. August 6, 2020

Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real-world pharmacoepidemiology study of post-marketing surveillance data. August 6, 2020

Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study. August 6, 2020

The effect of partial nephrectomy on blood pressure in patients with solitary kidney. August 5, 2020

[Complex network analysis of combination medication of patients with kidney malignant tumor based in real world]. August 5, 2020

Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment. August 5, 2020

Image-guided core biopsy of 2-cm or smaller renal tumors. August 5, 2020

The role of income disparities on survival in metastatic clear cell renal cell carcinoma in the targeted therapy era. August 4, 2020

Deceptive Features on Surveillance Imaging of Intraneural Metastatic Deposits In Metastatic Renal Cell Cancer. August 4, 2020

Page 132 of 458